RETROSPECTIVE ANALYSIS OF THE DIAGNOSIS OF COMMUNITY-ACCOMPANY PNEUMONIA IN CHILDREN
Abstract
Diseases of the respiratory system remain one of the urgent problems in pediatrics in terms of morbidity rate and complications among children. The purpose of the study is to retrospectively analyze the diagnosis of pneumonia outside the hospital in children. Materials and styles. 2019-2022 in the pediatric pulmonology department of the TTA multidisciplinary clinic with the diagnosis of pneumonia outside the hospital. retrospective analysis of medical history of treated children aged 3-18 years. Results. It became known that today, for clinical practice, there are the following difficulties in differentiating bacterial pneumonia outside the hospital from the viral type, which require their own solution: that is, the use of antibiotics before bacterial inoculation; the difficulty of obtaining a reliable sample of sputum from the respiratory tract in young children; application of the molecular diagnosis method in a narrow scope. The development of diagnostic tests with a high level of specificity and sensitivity in determining the etiology of pneumonia in sick children is considered highly effective for the activities of medical care institutions.
About the Authors
List of references
United Nations Children’s Fund. 2020. Pneumonia. Available at: https://data.unicef.org/topic/childhealth/pneumonia/
Chan JY, Stern DA, Guerra S, Wright AL,Morgan WJ, Martinez FD. Pneumonia in childhood and impaired lung function in adults: a longitudinal
study. Pediatrics. 2015; 135: 607–16. doi:10.1542/peds.2014-3060
Greenberg D, Leibovitz E. Communityacquired pneumonia in children: from diagnosis to treatment. Chang Gung. Medical Journal 2005; 28(11): 746-52.
Leung AKC, Wong AHC, Hon KL. Community-acquired pneumonia in
children. Recent Patents on Inflammation and Allergy Drug Discovery 2018; 12(2): 136-44. doi:10.2174/1872213X12666180621163821.
Vervloet LA, Marguet C, Camargos PA. Infection by Mycoplasma pneumoniae and its importance as an aetiological agent in childhood community-acquired pneumonias. Brazilian Journal of Infectious Diseases 2007; 11(5): 507-14. doi:1590/S141386702007000500012.
Karimdzhanov I.A., Madrakhimov P. M. Diagnosis and treatment of community-equired pneumonia (Literature review). Journal of biomedicine and practice. 2022; 3(7): 279-285.
Karimdzhanov I.A. Genetic Predisposition To Out-Of-Hospital Pneumonia In Children: A Modern Interpretation Of The Problem. Amer. Journal of medical sciences and pharmaceutical research. 2021;3 (5): 51-57.
Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean Journal of Pediatrics 2012; 55(2):42-7. ttps:doi:10.3345/kjp.2012.55.2.42.
Kashyap S, Sarkar M. Mycoplasma pneumonia: Clinical features and management. Lung India2010; 27(2): 75-85. doi:10.4103/0970-2113.63611.
World Health Organization Pneumonia Vaccine Trial Investigators’ Group. 2001. Standardisation of interpretation of chest radio-graphs for the diagnosis of pneumonia in children. Available at: http://www.who.int/vaccinesdocuments/D ocsPDF01/www616.
Robles A, Gil AS, Pascual V, Calbo E, Iladot E, Benet S, et al.Viral vs bacterial community-acquired pneumonia: Radiologic features. European
Respiratory Journal. 2011; 38: 2507.
Liyanage G, Adhikaram SGS, Chandrasiri SEHL, Aqiff M. Community acquired methicillin resistant Staphylococcus aureus soft tissue infection complicated by septicaemia, necrotising pneumonia, deep vein thrombosis and pyomyositis. Sri Lanka Journal of Child Health 2017; 46(1): 82. doi:10.4038/sljch.v46i1.8228
Li Y, Wang H, Wang F, Du H, Liu X, Chen P, et al. Comparison of hospitalised patients with pneumonia caused by COVID-19and influenza A in children under 5 years. International Journal of Infectious Diseases 2020; 98: 80-3. doi:10.1016/j.ijid.2020.06.026.
Raxmanova L.K., Nizametdinov I.N., Muxamedova P.I. Bolalardagi bronxopnevmoniyada timusning klinik-immunologik xususiyatlari. Sbornik nauch. trudov. Тashkent.-2003.-S.159-161.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.